Royal Medical Center review

The numbers need reconciliation

Royal Medical Center advertises a one-month sermorelin supply at $250 and a two-month supply at $450 on its therapy page. Another section labels the two-month selection $450 per month, while the general product catalog lists sermorelin acetate at $175. ^{[1] [2]} Those figures should not be compressed into one best price. I would pause before paying and ask which package is actually being offered, what is supplied and when the next charge occurs. The service may be workable, but the public presentation does not yet support a clean cost comparison.

The consultation can clarify the agreement

The practice describes physician-supervised care, telehealth and ongoing support. ^[1] Those are useful features if the actual appointment explains the proposed treatment and the responsibilities on both sides. Obtain a written plan that identifies medication, evaluation, supplies, testing and follow-up charges separately. A two-month supply can be a single purchase, a recurring plan or a monthly equivalent; the language needs to identify which. This matters before deciding that a longer selection offers better value, because the reader may be committing more money before knowing whether treatment will continue or remain appropriate.

Unfinished FAQs reduce confidence in the purchase

The therapy page’s frequently asked questions include placeholder text rather than answers about results, long-term safety and blood testing. ^[1] That is a practical weakness. These are precisely the topics a prospective patient needs explained before making an ongoing commitment. The problem is not evidence that a consultation will be poor; it is that the website leaves the buyer with less useful information than its polished offer suggests. The appointment should resolve those questions clearly, without relying on the fact that the treatment is described as working with natural hormone production.

Mechanism is not a promise of rejuvenation

Royal’s page emphasizes stimulation of the pituitary rather than direct growth-hormone replacement. ^[1] That is a relevant distinction, but it does not establish reliable improvements in sleep, cognition or healthy aging. Older GHRH experiments were small and used particular regimens and selected participants. In the six-week study by Vittone and colleagues, some functional measures changed while body composition and several metabolic measures did not. ^[3] A modern service should connect its proposed use to applicable evidence and uncertainty, rather than treat a physiological mechanism as proof of every benefit on a marketing list.

For the boundary between hormone response and clinical benefit, read GHRH physiology studies.

The pharmacy label still matters

A compounding or facility-registration statement should be read as information about the preparation and supplier, not as approval of the finished compounded prescription. Ask which pharmacy will dispense the proposed product and obtain the exact formulation, concentration, handling instructions and usable period. That information is necessary for a meaningful comparison with another service. It also prevents a low-looking supply price from concealing a different quantity or additional ingredient. The patient should leave the clinical discussion knowing what is being prescribed, who answers medication questions and what to do if the shipment or instructions create a problem.

The decision I would make

Royal merits further discussion only after the price conflict and missing FAQ answers are resolved in writing. The telehealth model could suit a reader who wants guided care, but convenience does not compensate for an unclear purchase. Compare the actual written proposal with another service on the same supply and follow-up basis. If the practice makes that agreement clear and explains a realistic treatment purpose, the offer can be assessed fairly. If the explanation remains a set of broad benefits beside inconsistent numbers, there is no strong reason to commit before exploring a more transparent alternative. Do not assume the smallest catalog figure is available for the therapy-page package. The selected offer needs its own itemization, and a verbal assurance should be reflected in the payment terms before the order proceeds.

Compare the clarified proposal with CoreAge Rx versus AgelessRx.

Understanding the cost

Selected package, delivery and recurring terms determine the final charge; no complete monthly price is asserted.